Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;121(3):149-53.
doi: 10.1111/j.1600-0404.2009.01308.x. Epub 2010 Jan 6.

Valproate in children with newly diagnosed idiopathic generalized epilepsy

K D Holland  1 , S Monahan, D Morita, G Vartzelis, T A Glauser
Affiliations

Valproate in children with newly diagnosed idiopathic generalized epilepsy

K D Holland et al. Acta Neurol Scand. 2010 Mar.

Abstract

Objectives: Sparse information on dose-response characteristics for initial antiepileptic drug monotherapy in children with idiopathic generalized epilepsy (IGE) is available. The aim of this study is to characterize the therapeutic dose of valproate in children with newly diagnosed IGE.

Materials and methods: Effect of initial valproate monotherapy and doses associated with seizure freedom were examined in consecutive children with IGE identified from a New Onset Seizure Clinic.

Results: Of 84 patients identified, 48 (57%) became seizure-free on valproate monotherapy and another 10 patients became seizure-free but discontinued VPA because of adverse effects. The mean dose in seizure-free children was 15.7 mg/kg/day and over 95% of IGE patients will respond below 25 mg/kg/day.

Conclusions: Half of children became seizure-free on valproate monotherapy and did so at modest doses.

PubMed Disclaimer

Conflict of interest statement

Disclosure

The authors have reported no conflicts of interest.

Figures

Figure 1
Figure 1
Outcome of children with newly diagnosed idiopathic generalized epilepsy treated with valproate.
Figure 2
Figure 2
Valproate dose leading to seizure control (open triangles) or discontinuation because of adverse effects (filled circles) in children with idiopathic generalized epilepsy.
See this image and copyright information in PMC

References

    1. Mohanraj R, Brodie MJ. Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting. Acta Neurol Scand. 2007;115:204–8. - PubMed
    1. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SA-NAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369:1016–1026. - PMC - PubMed
    1. Sato S, White BG, Penry JK, Dreifuss FE, Sackellares JC, Kupferberg HJ. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology. 1982;32:157–63. - PubMed
    1. Erenberg G, Rothner AD, Henry CE, Cruse RP. Valproic acid in the treatment of intractable absence seizures in children: a single-blind clinical and quantitative EEG study. Am J Dis Child. 1982;136:526–9. - PubMed
    1. Braathen G, Theorell K, Persson A, Rane A. Valproate in the treatment of absence epilepsy in children: a study of dose-response relationships. Epilepsia. 1988;29:548–52. - PubMed

Publication types